Algeria vs Vanuatu: New cases tested for RR-/MDR-TB
Algeria
1.0%
in 2023
Vanuatu
3.8%
in 2024
Algeria rank
183rd
Vanuatu rank
181st
New cases tested for RR-/MDR-TB over time
- Algeria
- Vanuatu
How they compare
Vanuatu currently reports 3.8% against 1.0% in Algeria, a difference of 2.8%.
That makes Vanuatu's figure about 3.8 times Algeria's.
The two have swapped places 3 times across 9 shared years of data; in 2014 it was Algeria ahead.
Algeria ranks 183rd and Vanuatu ranks 181st of 192 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 49.8% | 46.1% | Vanuatu |
| 2020s | 1.2% | 64.3% | 63.1% | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Algeria or Vanuatu?
- Vanuatu, at 3.8% against 1.0% in Algeria as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Algeria and Vanuatu?
- 2.8%, with Vanuatu ahead.
- How many years of comparable data are there for Algeria and Vanuatu?
- 9 years are reported by both, from 2014 to 2023.
- How do Algeria and Vanuatu rank globally for new cases tested for rr-/mdr-tb?
- Algeria ranks 183rd and Vanuatu ranks 181st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.